Produkty 511-26-2

CAS 511-26-2 występuje w naszej ofercie pod nazwami: MAP4343, MAP4343/ 99.32% (existing batch purity), MAP4343, 99.67%. Oferty producentów: GLPBio, TargetMol, Biosynth, Chemat, MedChemExpress. Dostępne opakowania: 10mg, 100mg, 10mM (in 1ml dmso), 25mg, 5mg, 50mg, 2mg, 1mg.

MAP4343
GLPBio, Biosynth, Chemat
  • opakowanie: 10mg, 100mg, 10mM (in 1ml dmso), 25mg
  • Warianty: 15
od 198,80
Zobacz produkt
MAP4343/ 99.32% (existing batch purity)
TargetMol
  • opakowanie: 2mg, 5mg, 10mg, 25mg
  • Warianty: 6
od 386,15
Zobacz produkt
MAP4343, 99.67%
MedChemExpress
  • opakowanie: 100 mg, 50 mg, 10mM/1mL, 25 mg
  • Warianty: 6
od 598,33
Zobacz produkt

1-[(3S,8S,9S,10R,13S,14S,17S)-3-methoxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone (CAS 511-26-2) to związek chemiczny o wzorze sumarycznym C22H34O2 i masie molowej 330.5 g/mol. Nazwa systematyczna IUPAC: 1-[(3S,8S,9S,10R,13S,14S,17S)-3-methoxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone. InChIKey: ZVGQOQHAMHMMNE-BIBIXIOVSA-N.

Dane identyfikacyjne
Wzór sumarycznyC22H34O2
Masa molowa330.5 g/mol
Nazwa IUPAC1-[(3S,8S,9S,10R,13S,14S,17S)-3-methoxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone
InChIKeyZVGQOQHAMHMMNE-BIBIXIOVSA-N
SMILESCC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OC)C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Pregnenolone methyl ether, Pregnenolone 3-methyl ether, Pregnenolone methyl ether [MI], 3beta-Methoxy-5-pregnen-20-one, 3beta-Methoxypregn-5-en-20-one, 3ss-MethoxyPREG, Pregn-5-en-20-one, 3-methoxy-, (3beta)-, orb1298059, (3beta)-3-Methoxypregn-5-en-20-one, Pregn-5-en-20-one, 3.beta.-methoxy-
Izomery (ten sam wzór sumaryczny)
ethyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate C22H34O2
(8S,9S,10R,13S,14S,17R)-17-(1-hydroxypropan-2-yl)-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C22H34O2
(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoic acid C22H34O2
(8S,9S,10R,13S,14S,17R)-17-[(2R)-1-hydroxypropan-2-yl]-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C22H34O2
methyl (6Z,9Z,12Z,15Z,18Z)-henicosa-6,9,12,15,18-pentaenoate C22H34O2
(8S,9S,10R,13S,14S,17R)-17-[(2S)-1-hydroxypropan-2-yl]-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C22H34O2
ethyl (5Z,8Z,11Z,14Z,17E)-icosa-5,8,11,14,17-pentaenoate C22H34O2
ethyl (5E,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate C22H34O2
ethyl (5Z,8E,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate C22H34O2
ethyl (5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoate C22H34O2
ethyl 19,19,20,20,20-pentadeuterioicosa-5,8,11,14,17-pentaenoate C22H34O2
(2S)-2-[(3S,8S,9S,10R,13S,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanal C22H34O2